Labd etf.

Technical Analysis for LABD - Direxion Daily S&P Biotech Bear 3X Shares. Buy or Sell? LABD closed up 5.87 percent on Tuesday, November 21, 2023, on 1.63 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.The ETF sees an average daily volume of about 136,000 shares. Direxion Daily S&P Biotech Bear 3x Shares (LABD) – Up 61.8% Direxion Daily S&P Biotech Bear 3x Shares seeks to deliver three times the inverse daily performance of the S&P Biotechnology Select Industry Index, which includes domestic companies from the biotechnology industry.Direxion Daily S&P Biotech Bear 3X Shares | historical ETF quotes and charts to help you track LABD exchange traded fund performance over time.This has resulted in huge demand for inverse or inverse-leveraged ETFs. ... (LABD): ETF Research Reports. Direxion Daily Semiconductor Bear 3X Shares (SOXS): ETF Research Reports.

The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, iShares Nasdaq Biotechnology ETF, ProShares UltraShort Nasdaq Biotechnology ETF, Direxion Daily S&P Biotech Bear 3x Shares ...Nov 13, 2023 · GLD - Free Report) dropped 2.6% last week as the greenback gained about 0.9%. As the mining stocks act as a leveraged play of the underlying metal, mining stocks and ETF slump more. As a result ... These include AdvisorShares MSOS 2x Daily ETF MSOX, M AX Airlines -3X Inverse Leveraged ETN JETD, Direxion Daily S&P Biotech Bear 3x Shares LABD, Direxion Daily MSCI Real Estate Bear 3X Shares DRV, and Daily S&P 500 High Beta Bear 3X Shares HIBS. The funds will remain investors’ darlings, provided sentiments remain …

About Direxion Daily S&P Biotech Bear 3X Shares ( LABD) LABD provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index. Trading Volume. 4.13M. 1 Year High. $29.92. Dividend Rate. $0.51. 1 Year Low.Inverse ETFs Up More Than 50% YTD. Here we highlight some Inverse ETFs that are up more than 50% so far in 2022. ... Direxion Daily S&P Biotech Bear 3X Shares LABD — up 83.1% year to date.

Wall Street was downbeat last week. Each of the key equity gadgets -- the S&P 500 (down 0.7%), the Dow Jones (down 0.01.%), the Nasdaq Composite (down 1.6%) and the Russell 2000 (down 1.8%) -- lost last week.1.00%. Stock Analysis Chart Headlines Holdings Ownership. The Direxion Daily S&P Biotech Bear 3X Shares (LABD) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index. LABD was launched on May 28, 2015 and is managed ...Overview Chart News Stats. 1D. ProCharts. S 18.89. B 18.96. Chart data is indicative and shows eToro's bid price. Direxion Daily S&P Biotech Bear 3X Shares live price charts, advanced technical analysis tools (Japanese candles & Fibonacci) and instrument performance comparisons.Like LABD, this fund also provides three times (3x) inverse exposure to the biotech sector but tracks the NASDAQ Biotechnology Index. It charges one bp lower in annual fees and trades in light ...

Wall Street was downbeat last week. Each of the key equity gadgets -- the S&P 500 (down 0.7%), the Dow Jones (down 0.01.%), the Nasdaq Composite (down 1.6%) and the Russell 2000 (down 1.8%) -- lost last week.

LABU, TZA and LABD among weekly ETF movers. Gainers: Direxion Daily Regional Banks Bull 3X Shares ( DPST) +28%. Direxion Daily S&P Biotech Bull 3x Shares ETF ( NYSEARCA: LABU) +26%. MicroSectors U ...

Heather Bell | Mar 28, 2016. Learn everything about Direxion Daily S&P Biotech Bull 3X Shares (LABU). Free ratings, analyses, holdings, benchmarks, quotes, and news. The Direxion Daily S&P Biotech Bull (LABU) and Bear (LABD) 3X Shares seek daily investment results, before fees and expenses of the performance of the S&P Biotechnology Select Industry Index.LABU, TZA and LABD among weekly ETF movers. Gainers: Direxion Daily Regional Banks Bull 3X Shares ( DPST) +28%. Direxion Daily S&P Biotech Bull 3x Shares ETF ( NYSEARCA: LABU) +26%. MicroSectors U ...Wall Street gave a dismal performance last month on Fed's longer-than-expected rate hike speculation, with all three major indices in red.Direxion Daily S&P Biotech Bear 3X Shares (LABD): ETF Research Reports ProShares UltraPro Short QQQ (SQQQ): ETF Research Reports Direxion Daily Semiconductor Bear 3X Shares (SOXS): ETF Research ...LABU and LABD were created on 5/28/2015. The daily returns of LABU are approximately 3X the returns of XBI. LABD is an inverse 3X leveraged ETF, and its daily returns are about -3X the returns of XBI.

Nov 6, 2023 · These leveraged ETFs seek a return that is 300% or -300% of the return of their benchmark index for a single day. The funds should not be expected to provide three times or negative three times the return of the benchmark’s cumulative return for periods greater than a day. Nov 23, 2023 · LABD ETF Database Category Average FactSet Segment Average; Number of Holdings 1 3 1 % of Assets in Top 10 100.00% 91.24% 100.00% % of Assets in Top 15 Direxion Daily S&P Biotech Bear 3x Shares LABD – Up 10% This product seeks to deliver three times the inverse daily performance of the S&P Biotechnology Select Industry Index. The fund has amassed $67.9 million in its asset base and has an average daily volume of about 2.7 million shares.The appeal for leveraged and inverse-leveraged ETFs has increased as these fetch outsized returns on quick market turns in a short span.Then there is the Direxion Daily S&P Biotech Bear 3X Shares (LABD), which is an inverse ETN and an interesting product to see on the most-shorted list. Inverse products are another way to bet ...Here are the three ETF ways to play the bearish trend in the biotech sector.

S&P Biotech Bear -3X Direxion (LABD) – Up 8.8% The space has been struggling for quite some time now. Due to higher rates, absence of cheaper capital and ebbing pandemic, the initial public ...

The Direxion Daily S&P Biotech Bear 3x Shares ETF (NYSEARCA:LABD) is an inverse leveraged ETF in biotechnology, with a leverage factor of -3. It was launched on May 28, 2015. It was launched on ...24 thg 4, 2022 ... 编者注：3倍做空标普生物技术ETF(LABD) 周涨近29%；2倍做空金矿指数ETF周涨近23%！德银预警：美联储激进升息经济硬着陆终将不可避免>>. 作者：Jling ...Direxion does have an inverse sister fund for LABU: The Direxion Daily S&P Biotech Bear 3X Shares ETF (LABD). Unlike a traditional ETF, LABU is not a collection of holdings designed to mirror an ...LABD also has the largest 12-month decay (-30.79%), whereas LABU shows the largest positive drift in the same time frame (7.78%), in a large loss. The inverse silver ETF ( ZSL ) has the highest ...Direxion Daily S&P Biotech Bear 3X Shares (LABD): ETF Research Reports. VanEck Biotech ETF (BBH): ETF Research Reports. First Trust NYSE Arca Biotechnology ETF (FBT): ETF Research Reports. Invesco Dynamic Biotechnology & Genome ETF (PBE): ETF Research Reports. Virtus LifeSci Biotech Products ETF (BBP): ETF Research ReportsGet a real-time stock price quote for LABD (Direxion Daily S&P Biotech Bear 3X Shares). Also includes news, ETF details and other investing information.LABD – Direxion Daily S&P Biotech Bear 3x Shares. The biotech fund, LABD which offers inverse exposure to the US Biotechnology sector, declined by over 11% last week amid rising rates and as investors continued to shun risky assets. The healthcare sector registered a fall of ~2.7%, and biotech was down ~2.5% in the last five days.Wall Street was downbeat last week. Each of the key equity gadgets -- the S&P 500 (down 0.7%), the Dow Jones (down 0.01.%), the Nasdaq Composite (down 1.6%) and the Russell 2000 (down 1.8%) -- lost last week.Direxion Daily S&P Biotech Bear 3X Shares (LABD): ETF Research Reports Direxion Daily 20+ Year Treasury Bear 3X Shares (TMV): ETF Research Reports MicroSectors U.S. Big Oil Index 3X Leveraged ETN ...

Winning ETFs in Focus. Against this backdrop, below we highlight a few biotech ETFs that were the least-hurt last week. First Trust NYSE Arca Biotechnology Index Fund FBT – Down 3% Past Week ...

The appeal for leveraged and inverse-leveraged ETFs has increased as these fetch outsized returns on quick market turns in a short span.

Nov 29, 2023 · 1.00%. Stock Analysis Chart Headlines Holdings Ownership. The Direxion Daily S&P Biotech Bear 3X Shares (LABD) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index. LABD was launched on May 28, 2015 and is managed ... The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is issued by Direxion. Asset Class Equity.These leveraged ETFs seek a return that is 300% or -300% of the return of their benchmark index for a single day. The funds should not be expected to provide three times or negative three times the return of the benchmark’s cumulative return for periods greater than a day.ETF Channel Staff - Thursday, January 5, 11:19 AM. Investors in Direxion Shares ETF Trust - Daily S&P Biotech Bear 3X Shs (LABD) saw new options begin trading today, for the February 24th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the LABD options chain for the new February 24th contracts and identified ...Inverse ETFs gained as stocks declined, driven by a fall in the jobless claims data, which led to rate hike jitters. 10. LABD – Direxion Daily S&P Biotech Bear 3x Shares.LABU ETF has been on a free fall for the past 12 weeks. Read more to know why I think this 3x leveraged bull ETF should be avoided. ... 1.01 percent, NRGU - 0.95 percent, SOXL - 0.9 percent, TNA ...MicroSectors U.S. Big Oil Index 3X Leveraged ETN NRGU, Direxion Daily S&P Biotech Bear 3x Shares LABD, Daily Dow Jones Internet Bear 3X Shares WEBS, Direxion Daily Semiconductor Bear 3x Shares ...Nov 24, 2023 · LABD LABU. LABD. LABU. The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. There is no guarantee the funds will achieve their stated investment objectives. The DRV ETF, which offers -3x daily leverage to an index comprised of U.S. REITs, was one of the top-performing inverse ETFs returning more than 17% last week. The real estate sector fell by ~4.7% last week and was the second-worst performing sector amid high mortgage rates, soaring prices, and hawkish Fed comments. 6.68.12. -2.22%. 524.63 K. Get detailed information about the Direxion Daily SP Biotech Bear 3X ETF. View the current LABD stock price chart, historical data, premarket price, dividend returns and more.Objective. The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the daily performance of the S&P Biotechnology Select Industry Index. The fund, under normal circumstances, invests at least 80% of its net assets (plus borrowing for investment purposes) in swap agreements, futures contracts, short ...

MSOX – AdvisorShares MSOS 2x Daily ETF. MSOX, which seeks to achieve 2x the total daily return of the AdvisorShares Pure US Cannabis ETF (MSOS) through swap agreements featured on the list with a 24% weekly return, as chances of federal legalization seem better. 4. LABD – Direxion Daily S&P Biotech Bear 3x Shares68.12. -2.22%. 524.63 K. Get detailed information about the Direxion Daily SP Biotech Bear 3X ETF. View the current LABD stock price chart, historical data, premarket price, dividend returns and more.LABD | A complete Direxion Daily S&P Biotech Bear 3X Shares exchange traded fund overview by MarketWatch. View the latest ETF prices and news for better ETF investing. …Direxion Daily S&P Biotech Bear 3X ETF Overview. Direxion Daily S&P Biotech Bear 3X ETF (LABD) is a passively managed Miscellaneous Trading--Inverse Equity exchange-traded fund (ETF). Direxion Funds launched the ETF in 2015. The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the daily performance ... Instagram:https://instagram. worth of 1964 half dollaranheuser busch sharevanguard international stock etfcall merrill lynch Dec 1, 2023 · These leveraged ETFs seek a return that is 300% or -300% of the return of their benchmark index for a single day. The funds should not be expected to provide three times or negative three times the return of the benchmark’s cumulative return for periods greater than a day. LABD LABU. LABD. LABU. The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. There is no guarantee the funds will achieve their stated investment objectives. which ai stocks to buywillton investment management Nov 24, 2023 · LABD LABU. LABD. LABU. The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. There is no guarantee the funds will achieve their stated investment objectives. ugg boots deckers Sep 26, 2023 · Direxion Daily S&P Biotech Bear 3x Shares LABD – Up 18.2%. ... Direxion Daily S&P Biotech Bear 3X Shares (LABD): ETF Research Reports. 2x Long VIX Futures ETF (UVIX): ETF Research Reports. View Top Holdings and Key Holding Information for Direxion Daily S&P Biotech Bear 3X Shares (LABD).Direxion Daily S&P Biotech Bear 3X Shares (LABD): ETF Research Reports Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X Shares (DRIP): ETF Research Reports MicroSectors Oil & Gas E&P 3x Inverse Leveraged ETNs (OILD): ETF Research Reports MicroSectors U.S. Big Oil Index 3X Inverse Leveraged ETN (NRGD): ETF Research …